Botanix Pharmaceuticals Limited
BXPHF · OTC
6/30/2025 | 6/30/2024 | 6/30/2023 | 6/30/2022 | |
|---|---|---|---|---|
| Market Cap | $813 | $451 | $104 | $53 |
| - Cash | $65 | $79 | $10 | $7 |
| + Debt | $32 | $0 | $0 | $0 |
| Enterprise Value | $780 | $372 | $94 | $46 |
| Revenue | $6 | $2 | $4 | $3 |
| % Growth | 178.2% | -45.1% | 36.9% | – |
| Gross Profit | $2 | -$2 | -$3 | -$8 |
| % Margin | 40.3% | -76.5% | -80.7% | -273.6% |
| EBITDA | -$82 | -$14 | -$9 | -$13 |
| % Margin | -1,427.1% | -666.2% | -237.6% | -471.5% |
| Net Income | -$86 | -$14 | -$9 | -$13 |
| % Margin | -1,500.6% | -670.2% | -242.7% | -478.1% |
| EPS Diluted | -0.047 | -0.009 | -0.008 | -0.014 |
| % Growth | -408.7% | -16.5% | 41.5% | – |
| Operating Cash Flow | -$79 | -$8 | -$12 | -$11 |
| Capital Expenditures | -$1 | -$18 | -$7 | -$3 |
| Free Cash Flow | -$80 | -$26 | -$19 | -$14 |